These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22623641)

  • 21. Cost-effectiveness analysis of preimplantation genetic screening and in vitro fertilization versus expectant management in patients with unexplained recurrent pregnancy loss.
    Murugappan G; Ohno MS; Lathi RB
    Fertil Steril; 2015 May; 103(5):1215-20. PubMed ID: 25772770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model.
    Moolenaar LM; Broekmans FJ; van Disseldorp J; Fauser BC; Eijkemans MJ; Hompes PG; van der Veen F; Mol BW
    Fertil Steril; 2011 Oct; 96(4):889-94. PubMed ID: 21868001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamete intrafallopian transfer. A cost-effective alternative to donor oocyte in vitro fertilization in women aged 40-42 years.
    Silva PD; Olson KL; Meisch JK; Silva DE
    J Reprod Med; 1998 Dec; 43(12):1019-22. PubMed ID: 9883404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving the cost-to-benefit ratio of in-vitro fertilization.
    Silva PD; Sorensen ML; Silva DE
    Wis Med J; 1997 Jan; 96(1):36-9. PubMed ID: 9020620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IVF treatment. A matter of lifestyle or life cycle.
    Munro R
    Nurs Times; 2002 Sep 10-16; 98(37):11. PubMed ID: 12271708
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-effectiveness modelling.
    Barlow DH
    Hum Reprod; 2001 Dec; 16(12):2479-80. PubMed ID: 11726561
    [No Abstract]   [Full Text] [Related]  

  • 27. A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts.
    Griffiths A; Dyer SM; Lord SJ; Pardy C; Fraser IS; Eckermann S
    Hum Reprod; 2010 Apr; 25(4):924-31. PubMed ID: 20106837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility.
    Pashayan N; Lyratzopoulos G; Mathur R
    BMC Health Serv Res; 2006 Jun; 6():80. PubMed ID: 16796733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some GP commissioners pay twice as much for IVF as others, review finds.
    Kmietowicz Z
    BMJ; 2014 Sep; 349():g5606. PubMed ID: 25214479
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of rescue IVF-ET treatment in the management of high response in stimulated IUI cycles.
    Olufowobi O; Sharif K; Papaioannou S; Mohamed H; Neelakantan D; Afnan M
    J Obstet Gynaecol; 2005 Feb; 25(2):166-8. PubMed ID: 15814397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model.
    Fiddelers AA; Dirksen CD; Dumoulin JC; van Montfoort AP; Land JA; Janssen JM; Evers JL; Severens JL
    Hum Reprod; 2009 Jul; 24(7):1648-55. PubMed ID: 19318703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NHS-funded IVF: consequences of NICE implementation.
    Goswami M; Hyslop LA; Murdoch AP
    Hum Fertil (Camb); 2013 Jun; 16(2):121-7. PubMed ID: 23638668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The costs to the NHS of multiple births after IVF treatment in the UK.
    Ledger WL; Anumba D; Marlow N; Thomas CM; Wilson EC;
    BJOG; 2006 Jan; 113(1):21-5. PubMed ID: 16398766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment.
    Bouwmans CA; Lintsen BM; Eijkemans MJ; Habbema JD; Braat DD; Hakkaart L
    Fertil Steril; 2008 Feb; 89(2):331-41. PubMed ID: 17662286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised controlled trial of intra-uterine insemination versus in vitro fertilisation in patients with idiopathic or mild male infertility.
    Elzeiny H; Garrett C; Toledo M; Stern K; McBain J; Baker HW
    Aust N Z J Obstet Gynaecol; 2014 Apr; 54(2):156-61. PubMed ID: 24579923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Charity calls on MPs to end postcode lottery in IVF treatment.
    Hitchen L
    BMJ; 2008 Jul; 337():a934. PubMed ID: 18650232
    [No Abstract]   [Full Text] [Related]  

  • 37. Government should investigate trusts that charge NHS patients for treatment, says Labour.
    O'Dowd A
    BMJ; 2012 Jul; 345():e4711. PubMed ID: 22782906
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint.
    Polinder S; Heijnen EM; Macklon NS; Habbema JD; Fauser BJ; Eijkemans MJ
    Hum Reprod; 2008 Feb; 23(2):316-23. PubMed ID: 18033807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost analysis of in vitro fertilization.
    Stern Z; Laufer N; Levy R; Ben-Shushan D; Mor-Yosef S
    Isr J Med Sci; 1995 Aug; 31(8):492-6. PubMed ID: 7635699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic implications of assisted reproductive technology.
    Levy MJ
    N Engl J Med; 1994 Dec; 331(23):1589. PubMed ID: 7969334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.